# rare diseases, today FDA approvals and PDUFA dates

Canonical: https://sec-api.dev/indications/rare-diseases-today

> 1 upcoming FDA catalyst in rare diseases, today: deramiocel (CAPR) on November 22, 2026 (PDUFA date).

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA decisions for rare diseases, today?

1 upcoming FDA catalyst in rare diseases, today: deramiocel (CAPR) on November 22, 2026 (PDUFA date). Press release filed with the SEC (EX-99): "Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026" [Calendar and source filings](https://sec-api.dev/indications/rare-diseases-today)

Source: Press release filed with the SEC (EX-99), accession 0001104659-26-125150, https://www.sec.gov/Archives/edgar/data/1133869/000110465926125150/capr-ex99d1.htm (retrieved 2026-11-12). Last confirmed 2026-11-10. Cite: https://sec-api.dev/indications/rare-diseases-today#answer

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| March 4, 2025 | [Deramiocel NDA/BLA acceptance](https://sec-api.dev/pdufa/deramiocel) | CAPR | rare diseases, today | completed | "On March 4, 2025, Capricor Therapeutics, Inc. (the "Company" or "Capricor") issued a press release announcing announced that the U.S. Food and Drug Administration ("FDA") has accepted for review its Biologics License Application ("BLA") seeking full approval for deramiocel, an investigational cell therapy, as a treatment for patients diagnosed with Duchenne muscular dystrophy cardiomyopathy." ([SEC Form 8-K](https://www.sec.gov/Archives/edgar/data/1133869/000155837025002097/capr-20250304x8k.htm)) |
| November 22, 2026 | [Deramiocel PDUFA date](https://sec-api.dev/pdufa/deramiocel) | CAPR | rare diseases, today | scheduled | "Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/1133869/000110465926125150/capr-ex99d1.htm)) |

## Drugs

- [Deramiocel](https://sec-api.dev/pdufa/deramiocel) (CAPR)

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/indications/rare-diseases-today.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "rare diseases, today FDA approvals and PDUFA dates." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/indications/rare-diseases-today

```bibtex
@misc{secapidev_indications_rare_diseases_today_20261116,
  title        = {rare diseases, today FDA approvals and PDUFA dates},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/indications/rare-diseases-today}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_indications_rare_diseases_today_20261116","title":"rare diseases, today FDA approvals and PDUFA dates","publisher":"sec-api.dev","URL":"https://sec-api.dev/indications/rare-diseases-today","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
